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SUMMARY - Demyelinating diseases of the central nervous system include a wide spectrum
of different disorders that may resemble multiple sclerosis (MS). The diagnosis of MS is based on
typical clinical and parac1inical criteria. The simplified McDonald's criteria, which combine clinical
picture, NMR findings, CSF analysis and visual evoked potentials, are appropriate for daily neuro-
logic routine. If some of these criteria are atypical, diagnostic algorithm should be extended to some
other procedures to excludeother diseases that can mimic MS not only in symptoms, signs or course
of the disease but also in laboratory findings. In such a case, an alternative, better explanation for
the clinical manifestations should be considered and performing specific tests is helpful to exclude
alternative diagnoses.
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Introduction
Demyelinating diseases of the central nervous
system are divided into inflammatory and non-in-
flammatory diseases. Inflammatory diseases can be
idiopathic and include clinical isolated syndrome,
multiple sclerosis (MS), acute disseminated enceph-
alomyelitis (ADEM) and optic neuromyelitis, and
specific demyelinating diseases that include neurosar-
coidosis, neuroborreliosis, and demyelinating diseases
in connecting tissue disorders. Non-inflammatory
demyelinating diseases are vascular, metabolic, toxic
and different genetic disorders. All of these demyeli-
nating diseases can mimic MS as the most common
demyelinating disease in clinical features, course of
the disease and paraclinical criteria. Therefore, a wide
spectrum of diagnostic procedures is by no means in-
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frequently needed to make the diagnosis and to start
the treatment.
Fifty years ago, the diagnosis of MS was exclu-
sively based on 'dissemination in time and space', i.e.
occurrence of two different symptoms at different
time point, as the result of involvement of different
parts of the central nervous system. Today, a variety
of diagnostic methods (nuclear magnetic resonance
(NMR) of the brain and spinal cord, specific finding
in cerebrospinal fluid (CSF) and visual evoked poten-
tials (VEP)) are available upon which the paraclini-
cal criteria are based--'. However, despite their high
sensitivity, these methods are not specific enough to
make an accurate diagnosis due to different clinical
presentation, especially in the early course of the dis-
ease, which can pose a major problem.
Differential Diagnosis of Demyelinating Diseases
The most common presentations in a clinical iso-
lated syndrome are optic neuritis and transverse my-
elitis. Fifty percent of patients presenting with optic
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neuritis develop MS within the next 15 years.'. Bi-
lateral or rapidly sequential optic neuritis could be
caused by the toxic effect of methanol or tobacco, or
by vitamin B12 deficiency, and can be part of a spe-
cific inflammatory disease such as sarcoidosis, vascu-
litis or sistemc lupus erythematosus (SLE), or may be
due to infection, ischemia, tumor growth or Leber's
hereditary optic neuropathy.
Transverse myelitis mostly affects thoracic spi-
nal cord. Idiopathic form affects the whole transverse
course of the cord causing progressive motor weakness,
sensory loss and incontinence". Partial cord lesion is a
more specific manifestation of transverse myelitis in
MS. The primary causes to be considered include post-
infection (varicella, Epstein-Barr virus, mycoplasma,
herpes zoster), post-vaccination (influenza), systemic
inflammatory disorders (sarcoidosis, SLE, Sjogren's
syndrome, antiphospholipid syndrome, giant cell ar-
teritis). Typical CSF findings are pleocytosis, proteino-
rachia, and rarely oligoclonal bands (aCB).
A combination of optic neuritis and severe form
of transverse myelitis is typical for Devic's disease or
neuromyelitis optica. Brain NMR is normal in more
than 50% of cases, and aCB are positive in a small
percent. A specific finding are serum anti-aquaporin-4
IgG antibodies'.
Disseminated demyelinating diseases include
ADEM and variants of MS (Marburg disease,
Shilder's diffuse sclerosis and Baloo's concentric scle-
rosis).
ADEM occurs predominantly in children and
young adults as a consequence of prior virus infec-
tion or vaccination, or it can be idiopathic". Typical
is the syndrome of meningoencephalomyelitis. CSF
and NMR findings are very similar in MS, although
demyelinating lesions are more symmetric and usually
larger. aCB are transiently positive and disappear in
6 months. ADEM can be multiphasic or recurrent,
which is hardly distinguishable from MS.
Marburg disease and Schilder's diffuse sclerosis
have an aggressive course leading to death in weeks
to months. Schilder's diffuse sclerosis is characterized
by cortical dysfunction (dementia, hemiplegia, corti-
cal blindness and deafness). Baloo's concentric sclero-
sis is characterized by specific demyelinated plaques
in which concentric rings of demyelination alternate
with normal myelin?
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Inherited disorders of adrenoleukodystrophy and
metachromatic leukodystrophy can resemble progres-
sive MS. These disorders are specific for positive fami-
ly history, disturbed intellectual development, adrenal
gland insufficiency and abdominal symptoms. aCB
are absent.
In the group of infectious diseases, neuroborre-
liosis, neuroAIDS and neurosyphilis can present as
demyelinating diseases. Neuroborreliosis is character-
ized by myelitis, cerebellar ataxia and recurrent crani-
al neuropathies". NMR and CSF findings can be very
similar to those in MS, so that definitive diagnosis
depends on ELISA and Western blot serologic analy-
sis of serum and CSF. Demyelinating changes seen in
neuroAIDS are mostly caused by progressive multifo-
cal leukoencephalopathy as a consequence of]C virus.
Neurosyphilis is increasing in frequency, but due to
NMR rarely causes a picture confused with MS.
Cerebral vasculitis presents as primary vasculitis
of the brain and spinal cord, or more commonly as
part of systemic diseases (Wegener granulomatosis,
SLE, Sjogren's syndrome, rheumatoid arthritis), or it
can be seen in drug addicts (cocaine, heroin)". Neuro-
logic complications are the second cause of morbidity
in SLE, next to nephrologic ones". It can present with
headache, epilepsy, ischemic attacks, encephalopathy,
myelopathy, or optic neuropathy. aCB are found in
about 50% of patients and disappear with immuno-
suppressant therapy. Sjogren's syndome can present
as optic neuropathy, cerebellar ataxia or internuclear
ophthalmoplegia, resembling MS. Characteristic
signs are xerostomia, xerophthalmia, involvement of
peripheral nervous system, and epileptic and ischemic
attacks.
Neurosarcoidosis presents with cranial nerve in-
volvement, involvement of peripheral nerovus system
and cognitive impairment. aCB can be found in CSF.
NMR of the brain is specific due to white matter le-
sions and leptomeningeal enhancement".
Behcet's disease is a multisystemic inflammatory
disease that affects CNS in about 5% of cases. aCB
are uncommon, and NMR abnormalities are nonspe-
cific, so brain biopsy may be required.
Vascular diseases of the CNS, especially arterio-
venous malformations, embolization of endocarditic
vegetations or atrial myxoma can mimic the symp-
toms of MS.
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Malignant diseases such as lymphoma, foramen
magnum tumors or multifocal gliomas can resemble
MS.
Diagnostic Algorithm ofDemyelinating Diseases
According to all these possible differential diag-
noses, a broad spectrum of diagnostic procedures may
occasionally be required. We usually start with thor-
ough history and physical examination, then the fol-
lowing studies are performed": 1) NMR of the brain
and spinal cord using T1, T2 and FLAIR sequence
and gadolinium as a paramagnetic contrast medium,
to asses the activity ofdemyelinating disorder; 2) lum-
bar puncture with analysis of IgG index and aCB in
serum and CSF, MRZ reaction; 3) neurophysiologic
studies: visual, auditory and somatosensory evoked
potentials; 4) hematologic and biochemical analysis
of peripheral blood (complete blood count, eryth-
rocyte sedimentation rate (ESR), coagulogram, C-
reactive protein (CRP), protein S, antithrombin III,
serum immunoelectrophoresis); 5) molecular analy-
sis of prothrombotic factors (FII, factor V Leiden,
MTHFR, PAI-1); 6) immunologic analysis (ANCA,
ANA, ENA, antiDNA, aCL, C3, C4, CIC); 7) thy-
roid gland hormones; 8) vitamin B12 and folic acid; 9)
serologic analysis for neurotropic viruses and Borrelia
burgdorftri, and serologic analysis for HIV, hepatitis B
and C; 10) VLDRL, TPHA; 11) cardiac studies; and
12) brain biopsy.
Conclusion
Due to the very broad spectrum of differential di-
agnosis of demyelinating diseases, we have to strictly
follow the eligible diagnostic algorithm for MS. Most
of these procedures are not obligatory if the main
clinical and paraclinical criteria are present. Atypical
systemic features such as fever, night sweats, weight
loss, arthropathy, rash, ulcers, dry mouth and eyes,
ocular disease; atypical neurologic features such as
persistent headache, fits, encephalopathy, meningi-
tis, movement disorders, stroke-like events, periph-
eral neuropathy; and atypical laboratory findings such
as raised ESR and/or CRP, absent aCB, persistent
pleocytosis, normal NMR or pronounced meningeal
enhancement, should prompt a doubt in the diagnosis
of MS, although it is possible that MS coexists with
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some other demyelinating disease. After all the above
mentioned diseases have been ruled out, a finding
of demyelinating lesions in the brain or spinal cord
points to two options: MS or possible MS. Then, we
are exactly where we were 50 years ago: waiting for
'dissemination in time and space'.
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Saietak
DIFERENCIJALNA DIJAGNOSTIKA I DIJAGNOSTICKI ALGORITAM ZA DEMIJELINIZACIJSKE
BOLESTI
L. DeimalJ-GrbelJa, R. Covii-Negovetii i V Demarin
Demijelinizacijske bolesti sredrsnjega zrvacnog sustava cine sirok spektar razlicitih poremecaja koji mogu nalikovati
multiploj sklerozi. Dijagnoza multiple skleroze temeljena je na tipicnim kl inickim i paraklnnckim kriterijima. Pojedno-
stavljeni McDonaldovi kriteriji u kojima se kl inicka slika kombinira s nalazom magnetske rezonancije, nalazom cere-
brospinalne tekucine i vidnim evociranim potencijalima korisni su u svakodnevnoj neuroloskoj praksi. Ako [e neki od tih
kriterija atipican, treba prosirrti dijagnosticki po stupak kako bi se iskljuctle druge bolesti koje mogu oponasati multiplu
sklerozu ne sarno u simptomima, znacima iii tijeku bolesti, nego i u nalazima laboratorijskih pretraga. U svakom slucaju.
treba razrmsljati 0 drugom, boljem objasnjenju klmickih manifestacija te je izvedba specificnrh testova korisna u iskljuce-
nju alternativne dijagnoze.
Key words: Neurologija ~ standardi; DiJagnostika, diftrenciJalna; Bolesti zivcanog sustava - diJagnostika;Algoritmi; Demije-
linizaciJske bolesti - diJagnostika
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